One-year follow-up data on 515 patients who survived hospitalization with MB-creatine kinase-confirmed, acute non-Q wave myocardial infarction were analyzed for factors related to mortality (n=57) and late reinfarction (n=64). Twelve of 24 analyzed variables were significantly associated with mortality. Those factors, which were independently predictive of mortality by Cox regression analysis, were persistent ST depression (p=0.0009), a history of congestive heart failure (CHF) (p=0.0069), older age (p =0.0128), and ST elevation at hospital discharge (p=0.0173). In-hospital reinfarction achieved borderline significance (p=0.0512).
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Mortality during the follow-up period was 5.5% in patients with no ST depression, 10 .1% in those with ST depression at baseline or discharge, and 22.2% in patients with ST depression at baseline and discharge (i.e., "persistent" ST depression). The age-adjusted risk of mortality for patients with persistent ST depression, discharge-ST elevation, and CHF was 13 .99 times as high as was the risk for patients with no ST depression, no discharge-ST elevation, and no CHF.
Of the 483 patients with complete electrocardiographic data at both baseline and discharge, 203 (42%) could be stratified into a high risk population with a risk ratio for l-year mortality more than sevenfold that of patients with no risk factors. Although persistent ST depression was significantly associated with several measures of structural left ventricular damage, the independent significance of ST depression persisted even after adjusting for these factors. The independent predictors of late reinfarction (persistent ST depression, p=0.0058; Killip class II or III, p=0.0106; and left ventricular hypertrophy, p=0.0470) permitted a similar risk stratification. We conclude that 1) easily identified clinical and electrocardiographic factors permit stratification of patients with non-Q wave infarction into high-risk subsets who may benefit from aggressive therapy; 2) ST depression is a highly significant and independent predictor of poor prognosis; and 3) the powerful predictive value of persistent ST depression suggests that non-Q wave myocardial infarction patients with this depression should be viewed as potentially high-risk patients who may be candidates for additional noninvasive testing or early coronary angiography. (Circulation 1989; 80:1148 -1158 S tratification of postmyocardial infarction (MI) patients into low-and high-risk subgroups is vitally important in the overall investigation and management of patients, both acutely and long term. Risk stratification is particularly important during the first year after acute MI, the period Schechtman et al Risk Stratification in Non-Q Wave MI 1149 with non-Q wave MI. Non-Q wave infarction is associated with less myocardial necrosis and with a lower in-hospital mortality than Q-wave MI.5-10 Nevertheless, despite this favorable early prognosis, long-term survival of patients with non-Q wave MI is similar to that of patients with Q wave infarction.7-12 The high-risk period after Q wave infarction lasts for perhaps 8-12 weeks, whereas, after non-Q wave infarction, there is a vulnerable period that is characterized by reinfarction and sudden death, and it persists for at least 1 year. [8] [9] [10] Several studies have noted that early postinfarction angina associated with transient electrocardiographic changes defines a high-risk subset of patients with non-Q wave MI.13-'5 Others have hypothesized that many patients recovering from non-Q wave MI have extensive areas of jeopardized ischemic myocardium that results from an initial subtotal coronary occlusion. This incomplete infarction, together with insufficient or threatened collaterals, may create a vulnerability to repetitive ischemic events. If this hypothesis is correct, it may account, in some patients, for the comparatively poor longterm prognosis associated with this type of infarction.10,16-18Despite the recognition that patients with non-Q wave MI have heterogeneous risk profiles, a prevalent belief has been that the only way to identify the high-risk population is to perform cardiac catheterization, exercise thallium scintigraphy, or, both, on all patients with non-Q wave MI. Nevertheless, no previous study conducted in an explicitly defined population of MB-creatine kinase (CK) -confirmed non-Q wave infarctions has examined, through multivariate analysis, which of several easily measured clinical and electrocardiographic parameters may have independent prognostic significance.
The purpose of the present study was to report the results of the 1-year follow-up on patients enrolled into the Diltiazem Reinfarction Study. 19.20 The Diltiazem Reinfarction Study was a multicenter, double-blind, placebo-controlled, randomized clinical trial designed to determine whether prophylactic diltiazem would reduce the rate of in-hospital reinfarction in patients with MB-CK-confirmed non-Q wave MI. This report defines a set of routinely available parameters that permit the delineation of differential risk strata for 1-year mortality and late reinfarction in patients with non-Q wave MI. The analysis indicates that ST segment depression that is present at both hospital admission and discharge is a powerful independent predictor of adverse long-term outcome and that a small and easily identified set of predictor variables permits stratification of patients with non-Q wave MI into high-and low-risk subsets that warrant differential diagnosis and therapy.
Methods
The data base produced by the Diltiazem Reinfarction Study contains information on 576 patients with MB-CK-confirmed non-Q wave acute MI. To minimize the number of enrolled patients who would later develop Q waves, randomization did not occur until at least 24 hours after admission. The latest allowable randomization time was 72 hours after admission. Complete details of the organization and conduct of the Diltiazem Reinfarction Study have been reported elsewhere. [19] [20] Follow-up Procedures
Although the primary focus of the Diltiazem Reinfarction Study involved blinded therapy only during the acute hospitalization, the follow-up protocol was prospectively designed and implemented. Follow-up telephone interviews were conducted by institutional study coordinators both 6 months and 1 year after the index infarction. Information about mortality, recurrent MI, rehospitalization, and the frequency of coronary artery bypass surgery or angioplasty was collected from patients and physicians and, in the case of deceased subjects, from family members, friends, physicians, and hospital records. Death was defined as sudden if it occurred within 1 hour of the onset of symptoms. However, because of the inherent uncertainty involved in establishing the precise cause of death, data analysis focused on all-cause mortality.
Clinical and Laboratory Evaluation
After randomization, the following evaluations were performed: 1) daily clinical evaluation by the investigator; 2) 12-lead electrocardiogram on enrollment and daily for the first 5 days, followed by every other day, thereafter, for 14 
Definition of Predictor Variables
The variables that were investigated as potential predictors of 1-year Third, in-hospital reinfarction during the first 14 days after the onset of acute MI was defined as an increase of 50% or more in plasma MB-CK activity above baseline (mean of two preceding samples) in at least two samples, separated by a minimum of 6 hours within a 24-hour interval, with an absolute value of 14 or more IU/l in at least one sample. 19 Fourth, post-infarction angina associated with electrocardiographic changes was characterized by a new occurrence of typical ischemic chest pain during the 2-week study that was not associated with abnormal reelevation in plasma MB-CK activity and that was accompanied by concurrent transient ST segment or T wave changes. 13 Fifth, left ventricular hypertrophy was defined electrocardiographically by the presence of one or more of the following voltage criteria: R in I plus S in III greater than 25 mm; R in aVL greater than 11 mm; S in V1-V3 greater than 25 mm; R in Vs or V6 greater than 25 mm; S in V1 plus R in V5 or V6 greater than 35 mm; or S in V2 plus R in V6 greater than 35 mm. Because the trial design did not include two-dimentional echocardiography, radionuclide ventrigulography, or coronary angiography on all patients, the diagnosis of left ventricular hypertrophy was made on electrocardiographic grounds only.
Sixth, other predictor variables. A total of 24 variables were used as potential univariate predictors of 1-year mortality and reinfarction in this report. These included the above factors with ST segment elevation and depression analyzed at both study entry and hospital discharge. Additional predictor variables include male gender; smoking; obesity; age; assignment to the diltiazem-treatment group; T wave inversion; anterior infarct location; peak CK on the index infarction; Killip class II or III; postinfarction angina with or without electrocardiographic changes; progression to Q wave MI during hospitalization; and a history that predates the index non-Q wave MI of coronary artery bypass surgery, previous MI, hypertension, congestive heart failure, or diabetes. All predictor variables except for age and peak CK were dichotomous. Peak CK values were adjusted to account for different definitions of a "normal range" at the sites participating in the Diltiazem Reinfarction Study. The use of Killip class II or III as a predictor variable reflected the exclusion of patients in Killip class IV from the Diltiazem Reinfarction Study. For use in multivariate analysis, a single three-category measure of ST segment depression was defined. These categories were defined by 1) ST depression at neither baseline nor discharge; 2) ST depression at baseline or discharge, but not at both time points; and 3) ST depression at both baseline and discharge.
Statistical Analysis
Data were analyzed using the STATISTICAL ANALY-SIS SYSTEM,22'23 as implemented on the Washington University IBM mainframe computer system. Continuous data are expressed as mean+SD. Gehan's generalized Wilcoxon test was used to compare Kaplan-Meier survival curves. 24 The ratio of the risk of late mortality and late reinfarction (defined as mortality or reinfarction between hospital discharge and 1 year) among different groups of patients was estimated using the hazard-function ratios computed by Cox regression.25 The Cox model was also used to determine which variables had independent significance as predictors of mortality and late reinfarction. When the end point of the analysis was mortality or reinfarction, a Cox model that considered time to the first event in patients who reinfarcted and died at a later time was used. All reportedp values reflect two-sided hypothesis tests. Despite these relations, persistent ST depression was significantly and independently associated with mortality after adjusting for any one or for all of the variables contained in Table 3 .
The independent predictive significance of persistent ST depression was underscored by the continuing importance of that variable, regardless of the status of angina. Thus, in patients without angina, mortality was 7.0% (eight of 115) if ST depression was absent, and was 19.3% (11 of 57) 10 .5%); a history of congestive heart failure (p=0.0232, 19.0% versus 11.2%); diabetes (p=0.0465, 18.9% versus 11.4%); and age (p=0.0047), with those who reinfarcted being 3.7 years older (64.5±10.1 versus 60.8±9.8 years) than those who did not reinfarct. Reinfarction rates were 7.8% (15 of 192; 95% confidence bounds, 4.0-11.2%) among patients without ST depression, 12.3% (20 of 163; confidence bounds, 7.2-17.3%) in patients with ST depression at exactly one time point; and 21.4% (24 of 112; confidence bounds, 13.8-29.0%) in those with ST depression at both time points. This total population of 467 excludes 17 patients with follow-up mortality data in whom information about reinfarction was unavailable. Figure 3 contains the Kaplan-Meier reinfarction curves for group 1 (no ST depression), group 2 (ST depression at exactly one time point), and group 3 (ST depression at both time points). The reinfarction rate in group 3 differed significantly from the corresponding rates in the other two groups (p=0.0003 versus group 1; and p=0.0165 versus group 2). The difference between groups 1 and 2 was not significant.
Risk stratification. hypertrophy (p=0.0470) were the only independent predictors of reinfarction ( Table 4 ). The independent significance of these variables permitted stratification into low-and high-risk strata. The high-risk stratum contained all patients with persistent ST depression or with at least two other risk factors, with ST depression at a single time point being defined as a risk factor in this definition. Low-risk patients had, at most one risk factor and did not have persistent ST depression. The reinfarction rate was 20.2% (36 of 178; 95% confidence bounds, 14.3-26.1%) in the high-risk group and 8.0% (23 of 289; confidence bounds, 4.8-11.1%) in the low-risk group. The relative risk of reinfarction in the highcompared with the low-risk stratum was 2.54 (p<0.0001, confidence bounds, 1.56-4.14).
Predictors of Death or Reinfarction
There were 94 patients who either reinfarcted or died during the 1-year follow-up period. The same 24 variables that were used to predict mortality and reinfarction separately were analyzed to assess their relation with the occurrence of either of these events. A Cox model, which analyzed time to first event, found four variables that were independently predictive of the combined event. These were persistent ST depression (p=0.0004), age (p=0.0104), discharge ST elevation (p=0.0135), and Killip class (p=0.0335). Analysis of risk ratios yielded conclusions similar to those described separately for mortality and reinfarction.
Twenty-seven of the 64 patients who had reinfarctions died subsequent to that event. Thus, we compared the fatal with the nonfatal reinfarctions Figures 2A and 2B are striking in the degree to which they demonstrate a gradation in ascending risk with each added risk factor. However, many of the individual subsets summarized in those figures represent a few patients yielding wide confidence bounds on risk ratios and a corresponding uncertainty that the precise pattern observed within these small categories would be repeated in a second data set. Nevertheless, the independent significance of each variable was clear from the Cox models we have presented. Moreover, the risk strata we have defined provide confidence bounds that demonstrate the usefulness of these variables, and in particular of ST depression, in stratifying the risk of patients with non-Q wave infarction. The low-risk stratum consisted of 25.3% of the total sample and had an observed 2.5% mortality rate. The 32.7% of the sample in the medium-risk stratum (mortality 7.6%) had an unadjusted relative risk of 3.09 compared with the lowrisk group. Moreover, of particular importance, the unadjusted relative risk of the high-risk stratum, a group that contained 42% of the total sample and had a mortality of 19 However, several considerations suggest the need for more comprehensive, prospective investigation. The follow-up used in our study yielded precise information about mortality but not about cause of death. Thus, we did not assess the association between the risk factors we have defined and causespecific mortality. By trial design, noninvasive and invasive studies were not uniformly performed on all study participants, a circumstance that made it difficult to determine whether additional noninvasive diagnostic procedures such as ambulatory ECG recordings, stress thallium scintigraphy, twodimensional echocardiography, or radionuclide ventriculography could further aid in the process of risk stratification. In particular, we do not have data on left ventricular ejection fraction, which can influence outcome importantly. In addition, we did not collect follow-up data on the use of diltiazem. The principal significance of this report was the identification of factors that can delineate differential risk strata early in the course of non-Q wave MI. These observations should provide the basis for performing a more comprehensive prospective analysis of other variables that might refine our ability to stratify risk in these patients.
Potential Implications
This study was not intended to be an investigation into the mechanism of persistent ST depression. However, these findings are consistent with the hypotheses1014,32,33 that 1) non-Q wave MI patients have large residual areas of hypoperfused and ischemic myocardium subtended by a critically stenosed or subtotally occluded infarct-related coronary artery, 2) ST segment depression in non-Q wave MI may represent a clinical model of "hibernating myocardium" due to inadequate or threatened collaterals, or 3) that persistent ST depression may be a manifestation of "silent myocardial ischemia," which predisposes this subgroup to a higher incidence of subsequent cardiac events. Alternatively, it is possible that structural changes (i.e., cumulative post-MI left ventricular damage) may play an important role in the high-risk profile associated with non-Q wave MI patients who exhibit persistent ST depression.
Because we do not have data on ejection fraction, we cannot address the degree to which ST depression reflects "hibernating" or "stunned" myocardium and the degree to which this has contributed to the left ventricular dysfunction associated with congestive heart failure. Moreover, we believe that the presence of ST depression does not represent a reciprocal change in these patients because, by design, patients were enrolled 24-72 hours after admission. This ensured the elimination of all patients with high-magnitude ST segment elevation and attendant reciprocal ST depression indicative of evolving Q wave MI. Moreover, when ST depression was accompanied by ST elevation, they were usually found in the same lead group, mostly anterior, and with ST elevation being of small magnitude and in leads V1 and V2.
Although a significant role for structural changes in explaining the genesis of persistent ST depression is consistent with our data, this depression retained its independent importance after statistical adjustment for variables reflecting left ventricular injury. In particular, this was true of all the markers of structural damage summarized in Table 3 
